These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis. Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312 [TBL] [Abstract][Full Text] [Related]
5. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Yaster M; Tobin JR; Billett C; Casella JF; Dover G Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746 [TBL] [Abstract][Full Text] [Related]
6. Regional anesthesia and analgesia in sickle cell pain episodes: A scoping review. Howie BA; Rajput K; Chow R Interv Pain Med; 2022 Sep; 1(3):100108. PubMed ID: 39238512 [TBL] [Abstract][Full Text] [Related]
7. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790 [TBL] [Abstract][Full Text] [Related]
8. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation. Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324 [TBL] [Abstract][Full Text] [Related]
9. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617 [TBL] [Abstract][Full Text] [Related]
10. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series. Palm N; Floroff C; Hassig TB; Boylan A; Kanter J J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238 [TBL] [Abstract][Full Text] [Related]
11. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease. Puri L; Nottage KA; Hankins JS; Anghelescu DL Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040 [TBL] [Abstract][Full Text] [Related]
12. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease. De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799 [TBL] [Abstract][Full Text] [Related]
13. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization. Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292 [TBL] [Abstract][Full Text] [Related]
14. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis. Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614 [TBL] [Abstract][Full Text] [Related]
15. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Buchanan ID; Woodward M; Reed GW Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170 [TBL] [Abstract][Full Text] [Related]
16. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591 [TBL] [Abstract][Full Text] [Related]
17. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department. García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592 [TBL] [Abstract][Full Text] [Related]
18. Characterization of opioid use in sickle cell disease. Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799 [TBL] [Abstract][Full Text] [Related]
19. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease. Beyer JE J Pain Symptom Manage; 2000 Jan; 19(1):63-72. PubMed ID: 10687328 [TBL] [Abstract][Full Text] [Related]
20. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]